Encysive Pharmaceuticals Receives License to Sell Thelin in Ireland

Encysive Pharmaceuticals Inc. has made its pulmonary arterial hypertension drug Thelin commercially available in Ireland. The Houston-based biopharmaceutical company said Thelin is the first selective endothelin A receptor antagonist, and the first once-daily oral treatment for patients with PAH, which currently affects more than 100,000 people in North America and Europe.

>>> Discuss This Story

Back to news